FA
Hu
Biosimilar
Reset all filters

Min CHF:
Max CHF:
  1-30 of 1144
Supplier Product name Cat.no. Pack size Price
Recombinant anti-human-Amyloid Beta Antibody (Lecanemab Biosimilar) 12-9407-50 370,40
Theralizumab Biosimilar - Research Grade ICH5023-100MG ICH5023-1MG ICH5023-5MG ICH5023-10MG ICH5023-20MG ICH5023-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Anti-Human TNF alpha (Adalimumab) - Dylight 488® 12-8101-100 658,00
Anti-Human IL-6 (Sarilumab) Dylight® 488 12-8089-100 658,00
Anti-Human IL 12/23 (Briakinumab) Dylight® 488 12-8075-100 658,00
Anti-Human DR5 (Drozitumab) - Dylight® 488 12-8062-100 658,00
Anti-Human OX40L (Oxelumab) - Dylight® 488 12-8095-100 658,00
Anti-Human TNF alpha (Adalimumab) - APC 12-8099-50 541,00
Anti-Human TNF alpha (Adalimumab) - PE 12-8103-50 541,00
Anti-Human IL-6 (Sarilumab) - APC 12-8085-50 541,00
Anti-Human IL-6 (Sarilumab) - PE 12-8088-50 541,00
Anti-Human IL 12/23 (Briakinumab) - APC 12-8071-50 541,00
Anti-Human DR5 (Drozitumab) - APC 12-8061-50 541,00
Anti-Human DR5 (Drozitumab) - PE 12-8064-50 541,00
Anti-Human CD11a (Efalizumab) - APC 12-8011-50 541,00
Anti-Human CD11a (Efalizumab) - Dylight® 488 12-8013-50 658,00
Anti-Human CD11a (Efalizumab) - PE 12-8015-50 541,00
Anti-Human OX40L (Oxelumab) - APC 12-8094-50 541,00
Anti-Human OX40L (Oxelumab) - PE 12-8096-50 541,00
Caplacizumab Biosimilar - Research Grade ICH5082-100MG ICH5082-1MG ICH5082-5MG ICH5082-10MG ICH5082-20MG ICH5082-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Aducanumab Biosimilar - Research Grade ICH5008-100MG ICH5008-1MG ICH5008-5MG ICH5008-10MG ICH5008-20MG ICH5008-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Enfortumab Biosimilar - Research Grade ICH5070-100MG ICH5070-1MG ICH5070-5MG ICH5070-10MG ICH5070-20MG ICH5070-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Gantenerumab Biosimilar - Research Grade ICH5009-100MG ICH5009-1MG ICH5009-5MG ICH5009-10MG ICH5009-20MG ICH5009-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Nesvacumab Biosimilar - Research Grade ICH5010-100MG ICH5010-1MG ICH5010-5MG ICH5010-10MG ICH5010-20MG ICH5010-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Girentuximab Biosimilar - Research Grade ICH5013-100MG ICH5013-1MG ICH5013-5MG ICH5013-10MG ICH5013-20MG ICH5013-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Urelumab Biosimilar - Research Grade ICH5015-100MG ICH5015-1MG ICH5015-5MG ICH5015-10MG ICH5015-20MG ICH5015-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Daclizumab Biosimilar - Research Grade ICH5021-100MG ICH5021-1MG ICH5021-5MG ICH5021-10MG ICH5021-20MG ICH5021-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
  1-30 of 1144

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
Monday to Friday
08:00 – 12:00
13:00 – 17:00

Technical Support
tech@lucerna-chem.ch
Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

© Copyright 2021 Lucerna-Chem AG, Switzerland

Order Conditions | Privacy Policy | Terms & Conditions | Impressum